⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

July 1, 2024Clinical ophthalmologyOpen Access

Subcutaneous Injections of Triamcinolone Acetonide for Upper Eyelid Retraction and Swelling Associated with Thyroid Eye Disease: A Retrospective Case Series Study

Ai Kozaki Rishu Inoue Naoko Yaji Koichi Nishiyama Toshu Inoue

View Full Paper

Ask AI

Bookmark

Share

Abstract

To evaluate the efficacy of subcutaneous injection of triamcinolone acetonide (SCTA) in treating upper eyelid retraction and swelling in patients with thyroid eye disease (TED).

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Kozaki et al. (2024) studied this question.

synapsesocial.com/papers/68e61dfeb6db6435875b0424 https://doi.org/10.2147/opth.s456543

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Percutaneous triamcinolone injection for upper eyelid retraction in thyroid eye disease2024 · 1 citations
2Efficacy and Systemic Effects of a Single Deep Orbital Triamcinolone Injection for Thyroid Eye Disease2024 · 2 citations
3Triamcinolone Acetonide and Botulinum Toxin A in the Treatment of Upper Eyelid Retraction in Thyroid-Associated Ophthalmopathy: A Clinical Study2024
4Peri-levator Betamethasone Versus Triamcinolone Injection in Management of Thyroid Eye Disease-related Upper Eyelid Retraction Without Proptosis2024 · 6 citations
5Real-World Anatomical Outcomes of Suprachoroidal Triamcinolone Acetonide Injections in a Large Retinal Practice over a 4-Year PeriodOriginal Research · 2026